ABSTRACT The aim of the study was to investigate the safety and efficacy of apomorphine SL (apo SL) 2 and 3 mg, using a dose-optimisation regime in 110 Asian men with erectile dysfunction

(ED) during a 10-week open-label study. Based on daily diaries kept by each patient, 63% showed an improvement in their sexual life. Patient responses to the International Index for Erection

Function 15 questionnaires showed that there was an improvement in erectile function from baseline score after treatment with apo SL (from 15.9 to 20.4), and intercourse satisfaction (from

7.7 to 9.9), as well as slight improvements in orgasmic function (from 6.8 to 7.5) and total satisfaction (from 41.9 to 50.8). There was no marked improvement seen in sexual desire. In

online access $259.00 per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes

which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY

OTHERS MIRABEGRON IMPROVES ERECTILE FUNCTION IN MEN WITH OVERACTIVE BLADDER AND ERECTILE DYSFUNCTION: A 12-WEEK PILOT STUDY Article 02 July 2021 COMBINATION THERAPY WITH TOPICAL ALPROSTADIL

AND PHOSPHODIESTERASE-5 INHIBITORS AFTER FAILURE OF ORAL THERAPY IN PATIENTS WITH ERECTILE DYSFUNCTION: A PROSPECTIVE, TWO-ARM, OPEN-LABEL, NON-RANDOMIZED STUDY Article 22 January 2021 DAILY

LOW-DOSE TADALAFIL MAY REDUCE THE PENILE CURVATURE PROGRESSION RATE IN PATIENTS WITH ACUTE PEYRONIE’S DISEASE: A RETROSPECTIVE COMPARATIVE ANALYSIS Article 13 December 2022 REFERENCES *

Thai Erectile Dysfunction Epidemiologic Study Group (TEDES). An epidemiological study of erectile dysfunction in Thailand (Part 1: prevalence). _J Med Assoc Thai_ 2000; 83: 872–879. * Thai

Erectile Dysfunction Epidemiological Study Group. Kongkanand A . Prevalence of erectile dysfunction in Thailand. _Int J Androl_ 2000; 23(Suppl 2): 77–80. Google Scholar  * Von Keitz AT et

al. A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose-escalation regimen in patients with erectile dysfunction. _BJU Int_

2002; 89: 409–415. Article  CAS  Google Scholar  * Dula E, et al. Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with

erectile dysfunction. The Apomorphine Study Group. _Urology_ 2000; 56: 130–135. Article  CAS  Google Scholar  * Rosen RC et al. The international index of erectile function (IIEF): a

multidimensional scale for assessment of erectile dysfunction. _Urology_ 1997; 49: 822–830. Article  CAS  Google Scholar  * Dula E, Bukofzer S, Perdok R, George M . Double-blind, crossover

comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. _Eur Urol_ 2001; 39: 558–564. Article  CAS  Google Scholar  * Mulhall JP, Bukofzer

S, Edmonds AL, George M . An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction. _Clin Ther_ 2001; 23: 1260–1271. Article  CAS  Google Scholar

  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Division of Urology, Department of Surgery, Chulalongkorn University Hospital, Bangkok, Thailand A Kongkanand, J Opanuraks

 & K Tantiwongse * Phramongkutklao Hospital, Rajadevi, Bangkok, Thailand N Choeypunt * Department of Surgery, Siriraj Hospital, Faculty of Medicine Siriraj Hospital, Mahidol University,

Bangkok, Thailand A Tantiwong & T Amornvejsukit Authors * A Kongkanand View author publications You can also search for this author inPubMed Google Scholar * J Opanuraks View author

publications You can also search for this author inPubMed Google Scholar * K Tantiwongse View author publications You can also search for this author inPubMed Google Scholar * N Choeypunt

View author publications You can also search for this author inPubMed Google Scholar * A Tantiwong View author publications You can also search for this author inPubMed Google Scholar * T

Amornvejsukit View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to A Kongkanand. RIGHTS AND PERMISSIONS Reprints and

permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Kongkanand, A., Opanuraks, J., Tantiwongse, K. _et al._ Evaluating dose regimens of apomorphine, an open-label study. _Int J Impot Res_ 15

(Suppl 2), S10–S12 (2003). https://doi.org/10.1038/sj.ijir.3900992 Download citation * Published: 24 June 2003 * Issue Date: 01 April 2003 * DOI: https://doi.org/10.1038/sj.ijir.3900992

SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to

clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * apomorphine SL * efficacy * tolerability * epidemiology